Key Market Indicators
Sales of antidepressant medications in Norway are estimated to drop to $22.54 million by 2026, a decrease of 5.3% from 2021's total of $31.92 million. This trend reverses the steady growth seen since 2007, when the Norwegian market was up 0.1% year on year. In 2021, Norway was the 16th-largest market for antidepressant medications, with Finland overtaking it at $31.92 million. Germany, Spain and Italy ranked second, third, and fourth, respectively.
